USMLE Step 1 & 2 Dementia and Delirium

Last updated: May 2, 2026

Dementia and Delirium questions are one of the highest-leverage areas to study for the USMLE Step 1 & 2. This guide breaks down the rule, the elements you need to recognize, the named traps that catch most students, and a memory aid that scales to test day. Read it once, then practice the same sub-topic adaptively in the app.

The rule

Delirium is an acute, fluctuating disturbance of attention and awareness caused by an underlying medical insult; dementia is a chronic, progressive decline in cognition with preserved attention until late stages. On exam day, your first job is to separate the two by tempo (hours-to-days vs months-to-years) and by attention (impaired in delirium, intact early in dementia). Your second job is to subtype the dementia by the earliest clinical signature — memory, behavior, language, motor, or visuospatial — and to hunt for the reversible mimics (B12, hypothyroidism, NPH, depression, medications) before you label anyone with Alzheimer disease.

Elements breakdown

Delirium

Acute, fluctuating disturbance of attention and awareness with disorganized thinking, caused by a medical condition, substance, or withdrawal.

  • Acute onset over hours to days
  • Inattention is the cardinal feature
  • Waxing and waning level of consciousness
  • Disorganized thinking, perceptual disturbances
  • Reversible if underlying cause is treated

Common examples:

  • Postoperative hip-fracture patient with UTI
  • ICU patient on benzodiazepines
  • Alcohol withdrawal at hospital day 3

Alzheimer Disease

Most common dementia; insidious anterograde memory loss from medial temporal degeneration with amyloid plaques and neurofibrillary tau tangles.

  • Gradual onset over years
  • Short-term memory loss earliest
  • Hippocampal/parietal atrophy on MRI
  • Apraxia, anomia, visuospatial loss later
  • Apolipoprotein E4 risk allele

Common examples:

  • Repeats questions, gets lost driving
  • Forgets recent conversations but recalls childhood

Vascular Dementia

Stepwise cognitive decline from cumulative cerebrovascular injury; deficits track infarct location.

  • Stepwise progression after strokes
  • Focal neurologic findings on exam
  • Vascular risk factors prominent
  • White matter and cortical infarcts on MRI
  • Executive dysfunction often early

Common examples:

  • Hypertensive smoker with prior lacunes
  • Sudden worsening after each TIA

Dementia with Lewy Bodies

Alpha-synuclein dementia with fluctuating cognition, visual hallucinations, and parkinsonism within one year of cognitive decline.

  • Fluctuating attention and alertness
  • Detailed visual hallucinations
  • Parkinsonism follows or parallels cognition
  • REM sleep behavior disorder
  • Severe neuroleptic sensitivity

Common examples:

  • Sees children in the room who are not there
  • Acts out dreams, falls from bed

Frontotemporal Dementia

Tau or TDP-43 frontotemporal degeneration presenting before age 65 with personality change or progressive aphasia.

  • Disinhibition, apathy, hyperorality earliest
  • Memory relatively preserved at onset
  • Frontal and anterior temporal atrophy
  • Pick bodies on histology in some
  • Onset typically 50s to early 60s

Common examples:

  • Previously reserved man now shoplifts
  • Eats sweets compulsively, loses empathy

Normal Pressure Hydrocephalus

Communicating hydrocephalus producing the wet-wacky-wobbly triad; one of the few surgically reversible dementias.

  • Magnetic gait comes first
  • Urinary incontinence
  • Subcortical cognitive slowing
  • Ventriculomegaly out of proportion to atrophy
  • Improvement after large-volume LP

Common examples:

  • Shuffling gait, recent-onset incontinence
  • Lift-off improves after CSF tap test

Reversible Mimics

Non-degenerative causes of cognitive impairment that must be excluded before diagnosing primary dementia.

  • B12 deficiency with macrocytosis and neuropathy
  • Hypothyroidism with TSH elevation
  • Depression presenting as pseudodementia
  • Polypharmacy, especially anticholinergics
  • Neurosyphilis, HIV, chronic subdural

Common examples:

  • Elderly vegan with paresthesias and dementia
  • Widow with poor effort on testing, says I do not know

Common patterns and traps

The Tempo-and-Attention Gate

Every cognitive-impairment vignette can be triaged by two questions: how fast did this come on, and is attention impaired right now? Acute onset over hours-to-days with inattention and waxing-waning consciousness is delirium until proven otherwise, regardless of any underlying dementia. Chronic, slowly progressive decline with preserved attention early is dementia, and the next move is subtyping plus reversible workup.

A vignette mentioning a recent hospital admission, surgery, infection, or new medication paired with fluctuating cognition is steering you toward delirium even if the patient also has baseline dementia.

The Earliest-Signature Subtyping Map

Once you have committed to dementia, the FIRST cognitive or behavioral domain to fail tells you the subtype. Memory loss first → Alzheimer disease. Personality and disinhibition first with spared memory → frontotemporal dementia. Visual hallucinations and parkinsonism within a year of cognitive change → dementia with Lewy bodies. Stepwise decline with focal deficits → vascular dementia. Gait and urinary symptoms preceding cognition → normal pressure hydrocephalus.

The vignette will plant ONE early-domain signature in the first two sentences (a 58-year-old who started shoplifting, an 80-year-old seeing children in the kitchen) — that signature is the diagnostic anchor.

The Reversible-Mimic Bait

USMLE loves a vignette that looks like Alzheimer but actually has a reversible cause hiding in the labs or medication list. Watch for macrocytic anemia and neuropathy (B12), elevated TSH and cold intolerance (hypothyroidism), recent loss with poor effort and prominent vegetative complaints (depression/pseudodementia), or a long med list including diphenhydramine, oxybutynin, or tricyclics (anticholinergic burden).

A vignette includes a buried lab abnormality (MCV 108, TSH 22) or medication detail; the correct next step is to treat the mimic, NOT to start donepezil or order an amyloid PET.

The Neuroleptic Sensitivity Trap

In dementia with Lewy bodies, dopamine antagonists (haloperidol, typical antipsychotics, even some atypicals) cause severe, sometimes life-threatening worsening of parkinsonism and autonomic instability. The exam will offer haloperidol for hallucinations or agitation in a patient whose history quietly tells you DLB.

An older patient with visual hallucinations, parkinsonism, and REM behavior disorder gets agitated; the wrong answer is haloperidol or risperidone, the right answer is to treat with low-dose quetiapine or an acetylcholinesterase inhibitor and remove offending agents.

The Surgically-Reversible Triad

Normal pressure hydrocephalus is the dementia exam writers reward you for catching, because shunting can reverse it. The triad — gait disturbance (magnetic, shuffling), urinary incontinence, and cognitive impairment — develops in that order, and the workup is MRI showing ventriculomegaly out of proportion to atrophy followed by a high-volume lumbar puncture (tap test) demonstrating gait improvement.

An older patient with a wide-based magnetic gait and recent-onset incontinence whose MRI shows enlarged ventricles; the correct next step is large-volume LP, not donepezil or carbidopa-levodopa.

How it works

Picture Mr. Alvarez, an 82-year-old with mild baseline forgetfulness, brought in two days after hip surgery because he is pulling at lines and seeing spiders on the wall. Attention testing — months of the year backward, digit span — falls apart, and his nurse reports he was lucid this morning. That fluctuation plus inattention is delirium, not progression of dementia, and your job is to find the trigger: check a urinalysis, review the medication list for opioids and diphenhydramine, screen for hypoxia and electrolyte derangement. Now contrast Mrs. Chen, an 80-year-old whose daughter says she has been repeating the same questions for two years, got lost driving home from a familiar grocery store, and recently could not name common objects, with a normal attention exam — that tempo and that signature point you toward Alzheimer disease, but only after you have checked TSH and B12 and reviewed her medication list. The exam wants you to make this two-step move every time: rule out delirium and reversible mimics before you commit to a degenerative dementia diagnosis.

Worked examples

Worked Example 1

Which of the following is the most likely explanation for this patient's acute change in mental status?

  • A Progression of underlying Alzheimer disease
  • B Delirium precipitated by urinary tract infection and anticholinergic medications ✓ Correct
  • C New-onset dementia with Lewy bodies
  • D Embolic stroke from postoperative atrial fibrillation

Why B is correct: The acute onset over hours, fluctuating level of consciousness (drowsy now, conversing normally at breakfast), inattention demonstrated on months-backward, and visual hallucinations in the setting of a documented UTI plus diphenhydramine (a strongly anticholinergic agent) and opioids define hyperactive delirium. Postoperative elderly patients with baseline cognitive vulnerability are the classic substrate, and identifying the precipitants — infection and offending medications — is the next step.

Why each wrong choice fails:

  • A: Alzheimer disease progresses over months to years with preserved attention until late stages; it does not produce hours-long fluctuations or new visual hallucinations, and it does not appear two days postoperatively in a previously functional patient. (The Tempo-and-Attention Gate)
  • C: DLB requires a chronic course with parkinsonism, recurrent well-formed visual hallucinations, and fluctuating cognition over time, not a 48-hour postoperative change; a single hospital episode does not establish a neurodegenerative diagnosis. (The Earliest-Signature Subtyping Map)
  • D: Embolic stroke produces focal neurologic deficits (hemiparesis, aphasia, gaze deviation) rather than fluctuating global inattention, and there is no history of arrhythmia or focal findings on the exam described.
Worked Example 2

Which of the following is the most likely diagnosis?

  • A Vascular dementia
  • B Frontotemporal dementia, behavioral variant
  • C Alzheimer disease ✓ Correct
  • D Pseudodementia of depression

Why C is correct: Insidious anterograde memory loss over years with preserved attention and social comportment, visuospatial loss (intersecting pentagons), and symmetric medial temporal (hippocampal) atrophy on MRI is the classic Alzheimer signature. The reversible mimics have been excluded — TSH and B12 are normal, there is no anemia, and there is no depressive history described — so committing to Alzheimer is appropriate.

Why each wrong choice fails:

  • A: Vascular dementia would show stepwise decline tied to discrete events, focal neurologic deficits, and infarcts or extensive white matter disease on MRI; this patient has a smoothly progressive course and a clean vascular MRI. (The Earliest-Signature Subtyping Map)
  • B: Behavioral-variant FTD presents with early personality change, disinhibition, apathy, or hyperorality with relatively preserved memory and typically begins before age 65; this patient is socially appropriate and her earliest deficit is memory. (The Earliest-Signature Subtyping Map)
  • D: Pseudodementia features prominent depressive symptoms, poor effort on testing with frequent I-don't-know answers, and intact recognition memory on cuing; none of those are present, and the imaging shows real atrophy rather than a normal scan. (The Reversible-Mimic Bait)
Worked Example 3

Which of the following is the most appropriate next step in management?

  • A Continue haloperidol and add benztropine
  • B Discontinue haloperidol and start rivastigmine ✓ Correct
  • C Start carbidopa-levodopa at standard Parkinson disease doses
  • D Start donepezil and refer for amyloid PET imaging

Why B is correct: Recurrent detailed visual hallucinations, fluctuating cognition, parkinsonism developing in parallel with cognitive decline, and REM sleep behavior disorder make this dementia with Lewy bodies, and the worsening on haloperidol is the textbook neuroleptic sensitivity reaction. The correct move is to stop the offending dopamine antagonist and start a cholinesterase inhibitor (rivastigmine or donepezil), which has the strongest evidence in DLB for cognition and hallucinations.

Why each wrong choice fails:

  • A: Continuing haloperidol in DLB risks severe rigidity, autonomic instability, and a neuroleptic malignant–like syndrome; benztropine adds anticholinergic burden that worsens cognition and hallucinations. (The Neuroleptic Sensitivity Trap)
  • C: Standard-dose levodopa can precipitate or worsen psychosis in DLB; if motor symptoms must be treated, low doses are used cautiously, but this is not the next step when the patient is currently rigid and confused from haloperidol.
  • D: Donepezil is reasonable in DLB, but ordering amyloid PET is wrong — amyloid imaging is used in atypical Alzheimer workups and would not change management here, and the priority is removing the offending neuroleptic before adding new agents or imaging. (The Earliest-Signature Subtyping Map)

Memory aid

Delirium = acute + inattention. Dementia subtype by the earliest red flag: memory first → Alzheimer; stepwise + focal deficits → Vascular; hallucinations + parkinsonism → DLB; personality first → FTD; wet-wacky-wobbly → NPH. Reversible workup: B12, TSH, depression, meds, neurosyphilis/HIV.

Key distinction

Delirium and dementia are distinguished by tempo and attention, not by the presence of confusion — both confuse the patient, but only delirium impairs attention acutely and fluctuates over hours.

Summary

Sort the tempo first (acute fluctuating = delirium), exclude reversible mimics second, then subtype the dementia by the earliest clinical signature.

Practice dementia and delirium adaptively

Reading the rule is the start. Working USMLE Step 1 & 2-format questions on this sub-topic with adaptive selection, watching your mastery score climb in real time, and seeing the items you missed return on a spaced-repetition schedule — that's where score lift actually happens. Free for seven days. No credit card required.

Start your free 7-day trial

Frequently asked questions

What is dementia and delirium on the USMLE Step 1 & 2?

Delirium is an acute, fluctuating disturbance of attention and awareness caused by an underlying medical insult; dementia is a chronic, progressive decline in cognition with preserved attention until late stages. On exam day, your first job is to separate the two by tempo (hours-to-days vs months-to-years) and by attention (impaired in delirium, intact early in dementia). Your second job is to subtype the dementia by the earliest clinical signature — memory, behavior, language, motor, or visuospatial — and to hunt for the reversible mimics (B12, hypothyroidism, NPH, depression, medications) before you label anyone with Alzheimer disease.

How do I practice dementia and delirium questions?

The fastest way to improve on dementia and delirium is targeted, adaptive practice — working questions that focus on your specific weak spots within this sub-topic, getting immediate feedback, and revisiting items you missed on a spaced-repetition schedule. Neureto's adaptive engine does this automatically across the USMLE Step 1 & 2; start a free 7-day trial to see your sub-topic mastery climb in real time.

What's the most important distinction to remember for dementia and delirium?

Delirium and dementia are distinguished by tempo and attention, not by the presence of confusion — both confuse the patient, but only delirium impairs attention acutely and fluctuates over hours.

Is there a memory aid for dementia and delirium questions?

Delirium = acute + inattention. Dementia subtype by the earliest red flag: memory first → Alzheimer; stepwise + focal deficits → Vascular; hallucinations + parkinsonism → DLB; personality first → FTD; wet-wacky-wobbly → NPH. Reversible workup: B12, TSH, depression, meds, neurosyphilis/HIV.

What's a common trap on dementia and delirium questions?

Calling fluctuating cognition Alzheimer instead of delirium or DLB

What's a common trap on dementia and delirium questions?

Skipping reversible workup (B12, TSH, depression) before diagnosing dementia

Related USMLE Step 1 & 2 sub-topics

Ready to drill these patterns?

Take a free USMLE Step 1 & 2 assessment — about 25 minutes and Neureto will route more dementia and delirium questions your way until your sub-topic mastery score reflects real improvement, not luck. Free for seven days. No credit card required.

Start your free 7-day trial